Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

T-cell Acute Lymphoblastic Leukemia · T-cell Acute Lymphoblastic Lymphoma · Acute Myeloid Leukemia · NK Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Contact: Study coordinator (Lung-Ji Chang, Ph.D) · c@szgimi.org · +86 0755-86573763

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

T-cell Acute Lymphoblastic Lymphoma · T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Houston, United States · Houston, United States

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

B-Cell Lymphoma · Myelodysplastic Syndromes (MDS) · Acute Myeloid Leukemia (AML)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

Acute Lymphoblastic Leukemia · Refractory Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2

Memphis, United States